Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.

Date Company Event Filing
Amneal Pharmaceuticals, Inc. AMRX Unregistered share sale Item 3.02 Form 8-K
Amneal Pharmaceuticals, Inc. AMRX Regulation FD disclosure Item 7.01 Form 8-K
Amplify Energy Corp. AMPY Results announced Item 2.02 Form 8-K
Amplify Energy Corp. AMPY Regulation FD disclosure Item 7.01 Form 8-K
Amplify Energy Corp. AMPY Other event Item 8.01 Form 8-K
Annexon, Inc. ANNX Officer or director change Item 5.02 Form 8-K
Annexon, Inc. ANNX Regulation FD disclosure Item 7.01 Form 8-K
Apogee Therapeutics, Inc. APGE Results announced Item 2.02 Form 8-K
Apple Hospitality REIT, Inc. APLE Regulation FD disclosure Item 7.01 Form 8-K
Applied Aerospace & Defense, Inc. AADX Officer or director change Item 5.02 Form 8-K
Applied Aerospace & Defense, Inc. AADX Regulation FD disclosure Item 7.01 Form 8-K
Aquestive Therapeutics, Inc. AQST Regulation FD disclosure Item 7.01 Form 8-K
Aquestive Therapeutics, Inc. AQST Other event Item 8.01 Form 8-K
Arcadia Biosciences, Inc. RKDA Delisting notice Item 3.01 Form 8-K
Archer Aviation Inc. ACHR Material agreement signed Item 1.01 Form 8-K
Archer Aviation Inc. ACHR Results announced Item 2.02 Form 8-K
Archer Aviation Inc. ACHR Unregistered share sale Item 3.02 Form 8-K
Archer Aviation Inc. ACHR Regulation FD disclosure Item 7.01 Form 8-K
Arena Group Holdings, Inc. PAAI Results announced Item 2.02 Form 8-K
Arena Group Holdings, Inc. PAAI Results announced Item 2.02 Form 8-K
Arena Group Holdings, Inc. PAAI Regulation FD disclosure Item 7.01 Form 8-K
Arq, Inc. ARQ Results announced Item 2.02 Form 8-K
Aspire Biopharma Holdings, Inc. ASBP Material agreement signed Item 1.01 Form 8-K
Aspire Biopharma Holdings, Inc. ASBP New debt or obligation Item 2.03 Form 8-K
Aspire Biopharma Holdings, Inc. ASBP Unregistered share sale Item 3.02 Form 8-K
Aspire Biopharma Holdings, Inc. ASBP Regulation FD disclosure Item 7.01 Form 8-K
Athene Holding Ltd. ATH-PA Results announced Item 2.02 Form 8-K
Axsome Therapeutics, Inc. AXSM Results announced Item 2.02 Form 8-K
Axsome Therapeutics, Inc. AXSM Other event Item 8.01 Form 8-K
BEASLEY BROADCAST GROUP INC BBGI Regulation FD disclosure Item 7.01 Form 8-K
BEYOND MEAT, INC. BYND Material agreement signed Item 1.01 Form 8-K
BITMINE IMMERSION TECHNOLOGIES, INC. BMNR Regulation FD disclosure Item 7.01 Form 8-K
BLACKBAUD INC BLKB Officer or director change Item 5.02 Form 8-K
BLUE RIDGE BANKSHARES, INC. BRBS Results announced Item 2.02 Form 8-K
BORGWARNER INC BWA Regulation FD disclosure Item 7.01 Form 8-K
BROWN & BROWN, INC. BRO Officer or director change Item 5.02 Form 8-K
BRT Apartments Corp. BRT Results announced Item 2.02 Form 8-K
BRT Apartments Corp. BRT Regulation FD disclosure Item 7.01 Form 8-K
Babcock & Wilcox Enterprises, Inc. BW Results announced Item 2.02 Form 8-K
Babcock & Wilcox Enterprises, Inc. BW Regulation FD disclosure Item 7.01 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.